Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
07 déc. 2017 19h25 HE
|
Aquinox Pharmaceuticals, Inc.
- Bone, Reproductive, and Urologic Drugs Advisory Committee Votes Unanimously in Favor of Unified IC/BPS Population for Clinical Trials - SILVER SPRING, Md., Dec. 07, 2017 (GLOBE NEWSWIRE) --...
Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference
22 nov. 2017 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results
08 nov. 2017 09h05 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
18 sept. 2017 16h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome
28 août 2017 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
- Meeting to be Held December 7, 2017 - VANCOUVER, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical...
Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results
08 août 2017 08h05 HE
|
Aquinox Pharmaceuticals, Inc.
- Enrollment in LEADERSHIP 301 with Rosiptor in IC/BPS Passes 50% - - Selection of CP/CPPS as Second Clinical Indication - VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Aquinox...
Aquinox to Present at Canaccord Genuity 37th Annual Growth Conference
02 août 2017 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Announce Second Quarter 2017 Financial Results
01 août 2017 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at Jefferies 2017 Global Healthcare Conference
01 juin 2017 09h00 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, June 01, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results
09 mai 2017 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, May 09, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...